Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for RedHill Biopharma (RDHL) over the last 5 years, with Q4 2016 value amounting to $128.8 million.

  • RedHill Biopharma's Shares Outstanding (Diluted Average) rose 1530.15% to $128.8 million in Q4 2016 from the same period last year, while for Dec 2016 it was $128.8 million, marking a year-over-year increase of 1530.15%. This contributed to the annual value of $128.8 million for FY2016, which is 1530.15% up from last year.
  • Per RedHill Biopharma's latest filing, its Shares Outstanding (Diluted Average) stood at $128.8 million for Q4 2016, which was up 1530.15% from $100.0 recorded in Q2 2016.
  • Over the past 5 years, RedHill Biopharma's Shares Outstanding (Diluted Average) peaked at $128.8 million during Q4 2016, and registered a low of $100.0 during Q2 2016.
  • In the last 5 years, RedHill Biopharma's Shares Outstanding (Diluted Average) had a median value of $52.6 million in 2012 and averaged $49.2 million.
  • As far as peak fluctuations go, RedHill Biopharma's Shares Outstanding (Diluted Average) soared by 10000.0% in 2015, and later plummeted by 1666.67% in 2016.
  • Over the past 5 years, RedHill Biopharma's Shares Outstanding (Diluted Average) (Quarter) stood at $52.6 million in 2012, then rose by 18.6% to $62.4 million in 2013, then soared by 39.83% to $87.2 million in 2014, then grew by 28.08% to $111.7 million in 2015, then increased by 15.3% to $128.8 million in 2016.
  • Its last three reported values are $128.8 million in Q4 2016, $100.0 for Q2 2016, and $111.7 million during Q4 2015.